205 related articles for article (PubMed ID: 8854885)
21. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK
Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903
[TBL] [Abstract][Full Text] [Related]
22. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
[TBL] [Abstract][Full Text] [Related]
23. A dual-circular plasmid structure dependent on DNA replication generated in monkey COS7 cells and cell extracts.
Jenab S; Johnson EM
Biochem Biophys Res Commun; 1989 Apr; 160(1):53-9. PubMed ID: 2540753
[TBL] [Abstract][Full Text] [Related]
24. Simian virus 40 (SV40) DNA replication: SV40 large T antigen unwinds DNA containing the SV40 origin of replication.
Dean FB; Bullock P; Murakami Y; Wobbe CR; Weissbach L; Hurwitz J
Proc Natl Acad Sci U S A; 1987 Jan; 84(1):16-20. PubMed ID: 3025851
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase I is preferentially associated with isolated replicating simian virus 40 molecules after treatment of infected cells with camptothecin.
Champoux JJ
J Virol; 1988 Oct; 62(10):3675-83. PubMed ID: 2843668
[TBL] [Abstract][Full Text] [Related]
26. Topoisomerase inhibitors can selectively interfere with different stages of simian virus 40 DNA replication.
Snapka RM
Mol Cell Biol; 1986 Dec; 6(12):4221-7. PubMed ID: 3025645
[TBL] [Abstract][Full Text] [Related]
27. [Topoisomerase I cleavage site in the regulatory zone of transcriptionally active minichromosomes of the SV40 virus located adjacent to a region, hypersensitive to DNAase I and segments recognizing topoisomerase II].
Vasetskiĭ ES; Kalandadze AG; Razin SV; Georgiev GP
Dokl Akad Nauk SSSR; 1989; 306(6):1493-6. PubMed ID: 2553371
[No Abstract] [Full Text] [Related]
28. Characterization of topoisomerase I and II activities in nuclear extracts during callogenesis in immature embryos of Zea mays.
Carballo M; Giné R; Santos M; Puigdomènech P
Plant Mol Biol; 1991 Jan; 16(1):59-70. PubMed ID: 1653630
[TBL] [Abstract][Full Text] [Related]
29. Exposure to camptothecin breaks leading and lagging strand simian virus 40 DNA replication forks.
Shin CG; Snapka RM
Biochem Biophys Res Commun; 1990 Apr; 168(1):135-40. PubMed ID: 2158312
[TBL] [Abstract][Full Text] [Related]
30. Characterization of novel human leukemic cell lines selected for resistance to merbarone, a catalytic inhibitor of DNA topoisomerase II.
Kusumoto H; Rodgers QE; Boege F; Raimondi SC; Beck WT
Cancer Res; 1996 Jun; 56(11):2573-83. PubMed ID: 8653700
[TBL] [Abstract][Full Text] [Related]
31. Decatenating activity of Escherichia coli DNA gyrase and topoisomerases I and III during oriC and pBR322 DNA replication in vitro.
Hiasa H; DiGate RJ; Marians KJ
J Biol Chem; 1994 Jan; 269(3):2093-9. PubMed ID: 8294462
[TBL] [Abstract][Full Text] [Related]
32. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
Hsiang YH; Lihou MG; Liu LF
Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
[TBL] [Abstract][Full Text] [Related]
33. Distribution of topoisomerase II cleavage sites in simian virus 40 DNA and the effects of drugs.
Pommier Y; Capranico G; Orr A; Kohn KW
J Mol Biol; 1991 Dec; 222(4):909-24. PubMed ID: 1662289
[TBL] [Abstract][Full Text] [Related]
34. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
[TBL] [Abstract][Full Text] [Related]
35. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
Kroeger PE; Rowe TC
Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
[TBL] [Abstract][Full Text] [Related]
36. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in simian virus 40-infected monkey cells.
Yang L; Rowe TC; Liu LF
Cancer Res; 1985 Nov; 45(11 Pt 2):5872-6. PubMed ID: 2996763
[TBL] [Abstract][Full Text] [Related]
37. A shuttle vector for analysis of illegitimate recombination in mammalian cells: effects of DNA topoisomerase inhibitors on deletion frequency.
Bae YS; Chiba M; Ohira M; Ikeda H
Gene; 1991 May; 101(2):285-9. PubMed ID: 1647363
[TBL] [Abstract][Full Text] [Related]
38. Arrest of segregation leads to accumulation of highly intertwined catenated dimers: dissection of the final stages of SV40 DNA replication.
Sundin O; Varshavsky A
Cell; 1981 Sep; 25(3):659-69. PubMed ID: 6269752
[TBL] [Abstract][Full Text] [Related]
39. Studies on the role of topoisomerases in general, gene- and strand-specific DNA repair.
Stevnsner T; Bohr VA
Carcinogenesis; 1993 Sep; 14(9):1841-50. PubMed ID: 8403208
[TBL] [Abstract][Full Text] [Related]
40. Rapid evaluation of topoisomerase inhibitors: caffeine inhibition of topoisomerases in vivo.
Shin CG; Strayer JM; Wani MA; Snapka RM
Teratog Carcinog Mutagen; 1990; 10(1):41-52. PubMed ID: 1971968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
